Tormere Analytics
OverviewStock ResearchPortfolio LabOptions LabCalculatorsWatchlist
Data Explorer
Pricing
Privacy PolicyTerms of Service

NVCT

$22.49-1.27%website ↗

Nuvectis Pharma, Inc.

Market Cap
$742M
Sector
Materials
Industry
Biotechnology
Beta
-0.23
5yr monthly vs SPY
Price Chart
Loading…

Signals

Insider Velocity
24.9x
buying
Congress
—
recent trades
Short Volume
64%
W/W -11.0pp

Market & Alt Data

News
15
recent articles
Activist
13D
BENTSUR
Analyst Consensus
Strong Buy
11 analysts
Velocity Score
24.85x
Current Rate (90d)
694.44/mo
Baseline Rate
0.00/mo
Unique Buyers (90d)
2
Sort by
Type
Trade DateFiledOwnerRoleTypeSharesPriceValueOwned After
2026-06-302026-07-01BENTSUR RONDirector & Chairman & CEOPurchase12.5K$20.00$250K3.69MView
2026-06-302026-07-01Mosseri Marlio Charles10% OwnerPurchase50.0K$18.32$916K3.19MView

Recent News

This Cal-Maine Foods Analyst Is No Longer Bullish; Here Are Top 4 Downgrades For Friday
Benzinga · 2026-09-04
Nuvectis Pharma To Participate in Upcoming Investor Conferences
Yahoo · 2026-09-03
This Toast Analyst Is No Longer Bullish; Here Are Top 3 Downgrades For Wednesday
Benzinga · 2026-09-02
This PG&E Analyst Is No Longer Bullish; Here Are Top 3 Downgrades For Tuesday
Benzinga · 2026-09-01

Informational purposes only, not investment advice.

This Sempra Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Monday
Benzinga · 2026-08-31
This Deere Analyst Turns Bullish; Here Are Top 5 Upgrades For Monday
Benzinga · 2026-08-31
This SolarEdge Analyst Turns Bullish; Here Are Top 2 Upgrades For Wednesday
Benzinga · 2026-08-26
This Nike Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday
Benzinga · 2026-08-26
This Atlassian Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday
Benzinga · 2026-08-26
This Five Below Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday
Benzinga · 2026-08-25
This AMD Analyst Turns Bullish; Here Are Top 5 Upgrades For Tuesday
Benzinga · 2026-08-25
This Agomab Therapeutics Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday
Benzinga · 2026-08-25
Nuvectis Stock Surges Around 97% in 3 Months: Here's Why
Yahoo Finance · 2026-08-19
StreetWatch: Nuvectis Pharma Eyes $9.8 Billion Oral PNH Market With Late-Stage NXP100 Backed by Strong Positive Phase 3 Data
Yahoo Finance · 2026-07-14
Wall Street Analysts See a 61.46% Upside in Nuvectis Pharma (NVCT): Can the Stock Really Move This High?
Yahoo Finance · 2026-07-08

Factor Profile

Pro
Pro feature

Fama-French factor analysis is available on the Pro plan.

Upgrade to Pro →
Pipeline
Phase 1
4 active trials · readout 2026-12